ATE293604T1 - Cyclische nitrone und pharmazeutische mittel die sie enthalten - Google Patents

Cyclische nitrone und pharmazeutische mittel die sie enthalten

Info

Publication number
ATE293604T1
ATE293604T1 AT02024174T AT02024174T ATE293604T1 AT E293604 T1 ATE293604 T1 AT E293604T1 AT 02024174 T AT02024174 T AT 02024174T AT 02024174 T AT02024174 T AT 02024174T AT E293604 T1 ATE293604 T1 AT E293604T1
Authority
AT
Austria
Prior art keywords
pharmaceutical agents
agents containing
cyclic nitrones
nitrones
cyclic
Prior art date
Application number
AT02024174T
Other languages
English (en)
Inventor
Craig E Thomas
Thomas L Fevig
Stephen M Bowen
Robert A Farr
Albert A Carr
David A Janovick
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE293604T1 publication Critical patent/ATE293604T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/10—Aza-phenanthrenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/08—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with a hetero atom directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT02024174T 1995-09-11 1996-08-15 Cyclische nitrone und pharmazeutische mittel die sie enthalten ATE293604T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US355195P 1995-09-11 1995-09-11

Publications (1)

Publication Number Publication Date
ATE293604T1 true ATE293604T1 (de) 2005-05-15

Family

ID=21706397

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02024174T ATE293604T1 (de) 1995-09-11 1996-08-15 Cyclische nitrone und pharmazeutische mittel die sie enthalten
AT96928900T ATE230731T1 (de) 1995-09-11 1996-08-15 Cyclische nitrone und pharmazeutische zusammensetzungen die sie enthalten

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT96928900T ATE230731T1 (de) 1995-09-11 1996-08-15 Cyclische nitrone und pharmazeutische zusammensetzungen die sie enthalten

Country Status (21)

Country Link
US (1) US5962469A (de)
EP (1) EP0863878B1 (de)
JP (1) JPH11512427A (de)
KR (1) KR100512675B1 (de)
CN (3) CN1500787A (de)
AR (1) AR004950A1 (de)
AT (2) ATE293604T1 (de)
AU (1) AU701989B2 (de)
CA (1) CA2231812C (de)
DE (2) DE69625701T2 (de)
DK (2) DK1288203T3 (de)
ES (2) ES2185797T3 (de)
HU (1) HUP9803028A3 (de)
IL (1) IL123345A (de)
MX (1) MX9801892A (de)
NO (1) NO311357B1 (de)
NZ (1) NZ316288A (de)
PT (2) PT863878E (de)
TW (1) TW337520B (de)
WO (1) WO1997010218A1 (de)
ZA (1) ZA967514B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002509147A (ja) * 1998-01-16 2002-03-26 センター ファーマシューティカルズ， インコーポレイテッド チオフェンニトロン化合物
EP1147113B1 (de) * 1999-01-19 2006-06-07 Neurosearch A/S Kondensierte heterocyclische verbindungen und ihre verwendung zur behandlung von neurodegenerativen erkrankungen
CN100513395C (zh) * 2006-04-17 2009-07-15 中国科学院化学研究所 一种制备多羟基环状硝酮的方法
CN101565453B (zh) * 2008-04-22 2011-12-21 中国科学院化学研究所 具有捕获自由基功能的硝酮类化合物及其制备方法与应用
ES2395803B1 (es) * 2011-08-01 2013-12-19 Consejo Superior De Investigaciones Científicas (Csic) - 80% Quinolilnitronas
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
US10660851B2 (en) 2015-01-02 2020-05-26 Rxos Medical Polyfunctional radical scavenger hydrogel formulation
CN108774274B (zh) * 2015-03-06 2020-11-03 北京大学 唾液酸甲酯甲苷衍生物及其合成方法和应用
WO2017137402A1 (en) * 2016-02-08 2017-08-17 Lunaphore Technologies Sa Methods of sample cycle multiplexing and in situ imaging

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US35112A (en) * 1862-04-29 Improvement in head-rests for car-seats
US3044930A (en) * 1960-12-08 1962-07-17 Phillips Petroleum Co N-oxides of heterocyclic nitrogen compounds as bird and rodent repellents
US3796715A (en) * 1967-08-30 1974-03-12 Hoffmann La Roche 8-alkoxy-3,4-dihydroisoquinolines
US4123543A (en) * 1971-09-16 1978-10-31 Ab Kabi Derivatives of substituted indoline lactans with effect on the central nervous system
US4117144A (en) * 1971-09-16 1978-09-26 Ab Kabi Derivatives of substituted isoindolines with effect on the central nervous system
SE368009B (de) * 1971-09-16 1974-06-17 Kabi Ab
JPS6363851A (ja) * 1986-09-05 1988-03-22 孫七瓦工業株式会社 瓦の葺設方法
US5025032A (en) 1989-10-17 1991-06-18 Oklahoma Medical Research Foundation Phenyl butyl nitrone compositions and methods for treatment of oxidative tissue damage
ATE110565T1 (de) * 1989-10-17 1994-09-15 Oklahoma Med Res Found Verfahren und zubereitungen zur hemmung von mit oxidativer schädigung assoziierten krankheiten.
EP0590072B1 (de) * 1991-06-18 2001-12-05 Oklahoma Medical Research Foundation Radikalfänger ("spin traps") zur behandlung von mit oxidation von lipiden und proteinen verbundenen erkrankungen
US5292746A (en) * 1991-09-12 1994-03-08 Merrell Dow Pharmaceuticals Inc. Cyclic nitrones, pharmaceutical compositions thereof and their use in treating shock
TW257755B (de) * 1991-09-12 1995-09-21 Merrell Dow Pharma
US5455272A (en) * 1993-10-22 1995-10-03 Oklahoma Medical Research Foundation Spin trap nitronyl hindered phenols
US5405967A (en) * 1993-10-22 1995-04-11 Oklahoma Medical Research Foundation Spin-trap molecules 2-trifluoromethyl- of 5,5-dimethyl-1-dyrroline-N-oxide
CA2152363A1 (en) * 1993-10-25 1995-05-04 Edward G. Janzen Novel phosphorus-containing spin-trap compositions
US5488145A (en) * 1993-12-23 1996-01-30 Oklahoma Medical Research Foundation 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps
US5472983A (en) * 1994-04-14 1995-12-05 Centaur Pharmaceuticals, Inc. Benzamide-containing pharmaceutical compositions

Also Published As

Publication number Publication date
PT863878E (pt) 2003-04-30
DE69634647T2 (de) 2006-03-02
ES2239194T3 (es) 2005-09-16
IL123345A (en) 2003-07-31
AU6848696A (en) 1997-04-01
DE69634647D1 (de) 2005-05-25
AR004950A1 (es) 1999-04-07
NZ316288A (en) 2000-01-28
NO981054D0 (no) 1998-03-10
TW337520B (en) 1998-08-01
NO311357B1 (no) 2001-11-19
CN1500787A (zh) 2004-06-02
CN1500779A (zh) 2004-06-02
AU701989B2 (en) 1999-02-11
EP0863878B1 (de) 2003-01-08
KR100512675B1 (ko) 2006-08-10
DE69625701D1 (de) 2003-02-13
WO1997010218A1 (en) 1997-03-20
KR19990044557A (ko) 1999-06-25
IL123345A0 (en) 1998-09-24
ATE230731T1 (de) 2003-01-15
HUP9803028A3 (en) 1999-05-28
CA2231812C (en) 2002-08-06
ZA967514B (en) 1997-03-10
NO981054L (no) 1998-03-10
DK1288203T3 (da) 2005-07-11
CA2231812A1 (en) 1997-03-20
US5962469A (en) 1999-10-05
EP0863878A1 (de) 1998-09-16
CN1196050A (zh) 1998-10-14
DK0863878T3 (da) 2003-04-22
CN1250528C (zh) 2006-04-12
JPH11512427A (ja) 1999-10-26
PT1288203E (pt) 2005-08-31
DE69625701T2 (de) 2003-10-02
HUP9803028A2 (hu) 1999-04-28
MX9801892A (es) 1998-05-31
ES2185797T3 (es) 2003-05-01

Similar Documents

Publication Publication Date Title
DE69612211D1 (de) Tissueprodukte die weichmacher und silikonglykol enthalten
DE69618375D1 (de) Verpackung und Vorrichtung zu deren Herstellung
ATE228010T1 (de) Orale pharmazeutische dosierungsformen die einen protonenpumpeninhibitor und ein prokinetisches mittel enthalten
DE69435088D1 (de) Therapeutische und diagnostische mittel für die amyloidosis
DE69007886D1 (de) Östradiol enthaltende Mittel und Verfahren zur topischen Anwendung.
DE69302257D1 (de) Pilzhemmendes und hautheilungsförderndes Mittel
ATE237304T1 (de) Topische mittel, die eine öl-in-wasser emulsion und ein retinoid enthalten
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
BR9703624A (pt) Combinação formulação farmacêutica processo para o tratamento de depressão em um animal uso de mirtazapina uso de um ou mais srri's e embalagem
DE69635607D1 (de) Liposom-verstärkter immunoaggregations-test und testvorrichtung
FI955907L (fi) Laite farmaseuttisten aineiden antamiseksi
ATE243516T1 (de) Amoxicillin und clavulanat enthaltende arzneizubereitungen
DE69301477D1 (de) Arbeitsstation und Träger
DE69422130D1 (de) Osteometrie und osteometrische vorrichtung
HUT77293A (hu) Fogfehérítő készítmények és eljárás azok alkalmazására
DE69009045D1 (de) Kapsel für medizinische Zwecke und Vorrichtung zu deren Aktivierung.
DE3889302D1 (de) 9-(Acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde Mittel davon als aktiver Wirkstoff.
DE69520235D1 (de) Schweisshemmende mittel
DE69513803D1 (de) Alumoxanen und katalysatore die alumoxanen enthalten
ATE293604T1 (de) Cyclische nitrone und pharmazeutische mittel die sie enthalten
DE60036401D1 (de) Kosmetische mittel enthaltend anis-extrakt und retinoide
PT95656A (pt) Dispositivo de dupla extremidade para aplicacao e medicao de drogas
FI953173L (fi) Orto-aminosubstituoituja bentsolyyliguanidiinejä, menetelmä niiden valmistamiseksi, niiden käyttö lääkeaineena tai diagnostisena aineena sekä niitä sisältävä lääkeaine
DE69631402D1 (de) Polymermischungen die Polyoxaestern und Lactonpolymeren enthalten
BR9607169A (pt) Uso de meletonina e formulação farmacêutica para uso no tratamento de um viciado em drogas múltiplas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1288203

Country of ref document: EP

REN Ceased due to non-payment of the annual fee